SEC 13F Intelligence

Omega Fund Management, LLC / ARQT

Omega Fund Management, LLC’s Arcutis Biotherapeutics Inc Position

Does Omega Fund Management, LLC own Arcutis Biotherapeutics Inc (ARQT)? Not currently — the last reported position was 623.8K shares worth $13M in Q2 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$13M
Q2 2022
Shares
623.8K
% of Portfolio
+4.24%
Quarters Held
10
position exited

Position History ARQT

Reported value by quarter
Q1 ’20: $25MQ1 ’20Q2 ’20: $26MQ3 ’20: $19MQ3 ’20Q4 ’20: $18MQ1 ’21: $18MQ1 ’21Q2 ’21: $17MQ3 ’21: $15MQ3 ’21Q4 ’21: $13MQ1 ’22: $12MQ1 ’22Q2 ’22: $13Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2022623.8K$13M+4.24%
Q1 2022623.8K$12M+2.46%
Q4 2021623.8K$13M+1.83%
Q3 2021623.8K$15M+1.00%
Q2 2021623.8K$17M+2.82%
Q1 2021623.8K$18M+2.46%
Q4 2020640.2K$18M+2.70%
Q3 2020658.9K$19M+5.22%
Q2 2020844.7K$26M+6.98%
Q1 2020844.7K$25M+10.42%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Omega Fund Management, LLC’s full portfolio or all institutional holders of ARQT.